insulin

The Federal Circuit has affirmed the Patent Trial and Appeal Board's decision invalidating two patents covering experimental gene therapy for hemophilia treatment, handing Pfizer a significant legal victory.

The Malaysian Health Ministry has extended its insulin supply contract with Biocon Biologics for an additional six months, from April 29 to October 28, 2025, continuing a partnership that has lasted nearly a decade.

Medtronic has announced plans to separate its Diabetes business into an independent, publicly traded company within the next 18 months, enabling both entities to focus on their core strengths and growth opportunities.

Gan & Lee Pharmaceuticals has signed a cooperation commitment letter with Brazil's Ministry of Health, becoming the first Chinese pharmaceutical company to participate in Brazil's PDP program for localizing insulin production.

Abbott's FreeStyle Libre continuous glucose monitoring system is the first CGM shown to reduce cardiovascular complication severity in diabetes patients, with data showing a 78% reduction in heart-related hospitalizations for Type 1 diabetes patients.